Global mometasone furoate market is estimated to be valued at US$ 1,182.9 million in 2022, and is expected to exhibit a CAGR 7.4% over the forecast period (2022-2030).
Increasing research and development activities related to mometasone furoate are expected to drive growth of market over the forecast period.
Increasing research and development activities in formulation and development of mometasone furoate are expected to fuel growth of the global mometasone furoate market over the forecast period. For instance, according to a research article published in, Journal of Dermatological Treatment, March 2022, a study was conducted in India, the objective of the study was to develop an aspasomal mometasone furoate gel that is biologically active, delivers medication at a controlled rate, and requires minimal doses to treat psoriasis. Aspasomal gel with mometasone furoate was developed and it was found that, aspasomal gel with mometasone furoate delivered the medication over a longer period of time and required fewer doses, expanding the scope of psoriasis treatment.
Figure 1: Global Mometasone Furoate Market Share (%) Analysis, By Dosage Form, 2022
Increasing product launches and approvals by market players are expected to drive growth of the global mometasone furoate market over forecast period.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients